In addition, contradictory to our fourth and fifth hypotheses, there was no significant relation between striatal DAT binding and anhedonia or depression at baseline for healthy controls and heroin-dependent subjects, and no relation between changes in DAT binding and changes in depression and anhedonia for heroin-dependent patients during XRNT treatment. Here, SLC6A3 is linked to depressive symptom measurement.